Masimo Corp (MASI) delivered better-than-expected financial results for the third quarter of fiscal 2025. The company's earnings per share (EPS) reached $1.32, surpassing Wall Street's consensus estimate of $1.23 by $0.09. Revenue matched expectations at $0.4 billion, maintaining the forecasted figure.
The announcement highlights Masimo's operational resilience in the competitive health care technology sector, where it specializes in patient monitoring technologies and solutions. Headquartered in Irvine, California, Masimo has developed a range of advanced monitoring products, including its proprietary Masimo Signal Extraction Technology (SET) pulse oximetry.
Masimo will host an earnings conference call after market close to discuss these results and provide additional insights into its business performance. Investors are encouraged to review the full earnings release and management commentary for further context on the quarter's achievements and future outlook.
The company, which went public on August 8, 2007, employs approximately 3,600 people and serves a variety of healthcare providers, including hospitals and emergency medical services. Upcoming earnings are scheduled for November 3, 2025, with an EPS estimate of $1.2253 and revenue also projected at $0.4 billion.